CALCA and arthritic joint disease: We have previously shown that the administration of a selective CGRP1 receptor antagonist (CGRP 8-37) into the CeA can inhibit pain behaviors in an acute arthritis model (Han et al., 2005), suggesting that CGRP-mediated mechanisms may influence pain-related amygdala function.